Fennec Pharmaceuticals Inc Stock price Other OTC
Equities
CA31447P1009
Biotechnology & Medical Research
Financials (USD)
Sales 2023 | 21.25M | Sales 2024 * | 49.19M | Capitalization | 300M |
---|---|---|---|---|---|
Net income 2023 | -16M | Net income 2024 * | 6M | EV / Sales 2023 | 14.3 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 6.09 x |
P/E ratio 2023 |
-18.7
x | P/E ratio 2024 * |
49.8
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 82.34% |
Latest transcript on Fennec Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |